IRIS - Res&Arch Institutional Research Information System - Research & Archive

CHIASSERINI, DAVIDE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.780
EU - Europa 1.418
AS - Asia 628
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 1
Totale 3.830
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.780
IE - Irlanda 418
IT - Italia 367
SG - Singapore 228
HK - Hong Kong 184
UA - Ucraina 151
CN - Cina 104
SE - Svezia 104
FI - Finlandia 81
FR - Francia 80
DE - Germania 63
VN - Vietnam 59
RU - Federazione Russa 47
RO - Romania 36
KR - Corea 22
GB - Regno Unito 19
TR - Turchia 19
CH - Svizzera 17
AT - Austria 10
NL - Olanda 9
BE - Belgio 4
CZ - Repubblica Ceca 4
GR - Grecia 3
UZ - Uzbekistan 3
EU - Europa 2
IN - India 2
LB - Libano 2
PL - Polonia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BG - Bulgaria 1
BR - Brasile 1
DK - Danimarca 1
IL - Israele 1
IQ - Iraq 1
IR - Iran 1
JP - Giappone 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
Totale 3.830
Salva come PNG Salva come JPEG
Città #
Dublin 416
Chandler 414
Hong Kong 184
San Mateo 183
Perugia 173
Singapore 172
Boardman 152
Altamura 93
Medford 81
Princeton 81
Jacksonville 74
Wilmington 70
Lawrence 68
Dong Ket 59
Beijing 51
Bucharest 34
Des Moines 34
Andover 31
Ann Arbor 27
Ashburn 25
Redmond 22
Seoul 21
Izmir 18
San Paolo di Civitate 18
Helsinki 17
Los Angeles 16
Saint Petersburg 15
Dallas 11
Saint Louis 10
New York 9
Norwalk 9
Lappeenranta 7
Santa Clara 7
Falls Church 6
Moscow 6
Redwood City 6
Rome 6
Terni 6
Lausanne 5
Milan 5
Woodbridge 5
Brussels 4
Fairfield 4
Shanghai 4
Utrecht 4
Auburn Hills 3
Dearborn 3
Detroit 3
Florence 3
Guangzhou 3
Houston 3
Mcallen 3
Munich 3
Agra 2
Amsterdam 2
Assisi 2
Brixen 2
Brno 2
Den Haag 2
Göttingen 2
Simi Valley 2
Tappahannock 2
Aksaray 1
Atlanta 1
Bratislava 1
Changsha 1
Charlotte 1
Chicago 1
Chieti 1
Corciano 1
Curitiba 1
Ergolding 1
Esslingen am Neckar 1
Fareham 1
Fremont 1
Geumjeong-gu 1
Gunzenhausen 1
Latina 1
London 1
Mogliano 1
Nanjing 1
Napoli 1
Nuremberg 1
Olomouc 1
Parma 1
Pars 1
Phoenix 1
Quanzhou 1
Radeberg 1
Rho 1
Rishon Le Zion 1
Sector 6 1
Spin 1
Spoleto 1
Taipei 1
Timisoara 1
Tokyo 1
Torino 1
Trapani 1
Trieste 1
Totale 2.743
Salva come PNG Salva come JPEG
Nome #
Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuospatial memory alteration 109
Cerebrospinal fluid β-glucocerebrosidase activity is reduced in parkinson's disease patients 92
Changes in CSF acetyl- and butyrylcholinesterase activity after long-term treatment with AChE inhibitors in Alzheimer's disease. 89
Analisi del proteoma di carcinomi papillari della tiroide positivi per la mutazione BRAFV600E 85
3-Bromopyruvate treatment induces alterations of metabolic and stress-related pathways in glioblastoma cells 78
Selective loss of glucocerebrosidase activity in sporadic Parkinson's disease and dementia with Lewy bodies 76
Cerebrospinal fluid biomarkers in Parkinson disease. 74
Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson’s Disease and Dementia with Lewy Bodies 73
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers. 71
Cytoskeletal perturbation leads to platelet dysfunction and thrombocytopenia in variant forms of Glanzmann thrombasthenia 70
L’analisi proteomica del carcinoma papillare della tiroide evidenzia modificazioni dello stato ossidoriduttivo e della struttura delle cellule tumorali 69
Diagnostic utility of cerebrospinal fluid α-synuclein in Parkinson's disease: A systematic review and meta-analysis 69
Performance of Aβ1-40, Aβ1-42, Total Tau, and Phosphorylated Tau as Predictors of Dementia in a Cohort of Patients with Mild Cognitive Impairment. 63
Cerebrospinal fluid lysosomal enzymes and α-synuclein in Parkinson's disease. 63
Mitochondria and the link between neuroinflammation and neurodegeneration. 62
Identification of differentially expressed proteins in papillary thyroid carcinomas with V600E mutation of BRAF 61
Identification and Partial Characterization of Two Populations of Prostasomes by a Combination of Dynamic Light Scattering and Proteomic Analysis 61
Effects of central and peripheral inflammation on hippocampal synaptic plasticity 59
Protein expression changes induced in murine peritoneal macrophages by Group B Streptococcus 57
Persistent activation of microglia and NADPH drive hippocampal dysfunction in experimental multiple sclerosis 56
Proteomic analysis of papillary thyroid carcinoma reveals demodulation of mechanisms regulating cell proliferation, susceptibility to oxidative stress and cellular aggregation 55
Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias. 55
Lysosomal enzyme activities in human brain 55
Erratum: Persistent activation of microglia and NADPH oxidase drive hippocampal dysfunction in experimental multiple sclerosis (Scientific Reports (2016) 6 (20926) DOI: 10.1038/srep20926) 53
Crosstalk between long-term sublethal oxidative stress and detrimental inflammation as potential drivers for age-related retinal degeneration 53
Cerebrospinal fluid hemoglobin levels as markers of blood contamination: relevance for α-synuclein measurement 51
Comprehensive library generation for identification and quantification of endometrial cancer protein biomarkers in cervico-vaginal fluid 51
CSF levels of heart fatty acid binding protein are altered during early phases of Alzheimer's disease. 50
Characterization of Two Populations of Prostasomes by Proteomics and Dynamic Light Scattering 50
Cerebrospinal fluid biomarkers for the diagnosis and prognosis of Parkinson's disease: protocol for a systematic review and individual participant data meta-analysis 50
Biomarkers in Parkinson's disease: From pathophysiology to early diagnosis 49
Molecular dynamic simulation of the catalytic domain of BRAF in response to activating and inactivating mutation 48
Lysosomal Dysfunction and α-Synuclein Aggregation in Parkinson's Disease: Diagnostic Links 47
Performance Evaluation of an Automated ELISA System for Alzheimer's Disease Detection in Clinical Routine 47
Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia 47
Measurement of CSF core Alzheimer disease biomarkers for routine clinical diagnosis: Do fresh vs frozen samples differ? 47
Role of CSF biomarkers in the diagnosis of prodromal Alzheimer's disease. 46
Changes in endolysosomal enzyme activities in cerebrospinal fluid of patients with Parkinson's disease. 46
Factors influencing the measurement of lysosomal enzymes activity in human cerebrospinal fluid. 46
Fingerprinting Alzheimer's Disease by 1H Nuclear Magnetic Resonance Spectroscopy of Cerebrospinal Fluid 46
Proteomic analysis of papillary thyroid carcinomas reveals demodulation of signal transduction pathways, increased resistance to oxidative stress and gain of invasive phenotype. 45
Diagnostic utility of CSF α-synuclein species in Parkinson's disease: Protocol for a systematic review and meta-analysis 42
CSF Biomarkers in Parkinson's disease 41
Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics 41
Origin of α-mannosidase activity in CSF 41
Role of FABP3 as biomarker in Alzheimer's disease and synucleinopathies 41
Proteomic changes induced by Group B Streptococcus in mouse peritoneal macrophages 40
Validation of microRNAs in Cerebrospinal Fluid as Biomarkers for Different Forms of Dementia in a Multicenter Study 40
PROTEOMIC ANALYSIS OF EXTRACELLULAR VESICLES IN ALZHEIMER’S DISEASE CEREBROSPINAL FLUID 40
Sistema immunitario e cefalee primarie 39
CSF proteome analysis in multiple sclerosis patients by two-dimensional electrophoresis. 39
Proteomic biomarkers for the detection of endometrial cancer 39
Fibroblast growth factor-2 levels are elevated in the cerebrospinal fluid of multiple sclerosis patients. 38
Differential protein expression in glioblastoma cells induced by 3-bromopyruvate 37
Modelli sperimentali 36
The use of missing values in proteomic data-independent acquisition mass spectrometry to enable disease activity discrimination 36
Evidence for Elevated Cerebrospinal Fluid ERK1/2 Levels in Alzheimer Dementia. 35
Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease. 35
Interleukin-17 affects synaptic plasticity and cognition in an experimental model of multiple sclerosis 35
Immunological profile of silent brain infarction and lacunar stroke. 34
Mortalin Inhibition in Experimental Parkinson's Disease 34
Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory study 34
A Practical Guide to Immunoassay Method Validation 34
Role of Lysosomal Enzymes in Parkinson’s Disease: Lesson from Gaucher’s Disease 33
Longitudinal changes in CSF alpha-synuclein species reflect Parkinson's disease progression 33
Expression of ionotropic glutamate receptor GLUR3 and effects of glutamate on MBP- and MOG-specific lymphocyte activation and chemotactic migration in multiple sclerosis patients. 32
Lysosomal enzymes in PD: further evidence is needed. 32
Italian consensus recommendations for a biomarker-based aetiological diagnosis in mild cognitive impairment patients 32
Extracellular Vesicles in Aging: An Emerging Hallmark? 31
No diurnal variation of classical and candidate biomarkers of Alzheimer's disease in CSF 30
The Clinical Use of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease Diagnosis: The Italian Selfie 30
Molecular characterization of colorectal adenomas reveals POFUT1 as a candidate driver of tumor progression 30
Standardization and harmonization of distributed multi-center proteotype analysis supporting precision medicine studies 29
Phosphatidylethanolamine Binding Protein 1 (PEBP1) in Alzheimer's Disease: ELISA Development and Clinical Validation 25
Proteomic analysis of cerebrospinal fluid extracellular vesicles: A comprehensive dataset 25
Interferon-β1a protects neurons against mitochondrial toxicity via modulation of STAT1 signaling: electrophysiological evidence. 25
Urinary Biomarkers and Their Potential for the Non-Invasive Detection of Endometrial Cancer 25
A prostate cancer proteomics database for swath-ms based protein quantification 25
Preanalytical Confounding Factors in the Analysis of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: The Issue of Diurnal Variation 24
Donor natural killer cells trigger production of beta-2-microglobulin to enhance post bone marrow transplant immunity 24
null 22
Glucocerebrosidase in Parkinson's disease: Insights into pathogenesis and prospects for treatment 21
Increased levels of CSF total but not oligomeric or phosphorylated forms of alpha-synuclein in patients diagnosed with probable Alzheimer's disease 21
Structural dynamics shape the fitness window of alanine:glyoxylate aminotransferase 20
Machine Learning Driven Profiling of Cerebrospinal Fluid Core Biomarkers in Alzheimer's Disease and Other Neurological Disorders 20
Non-Phosphorylated Tau as a Potential Biomarker of Alzheimer's Disease: Analytical and Diagnostic Characterization 20
C1q is increased in cerebrospinal fluid-derived extracellular vesicles in Alzheimer's disease: A multi-cohort proteomics and immuno-assay validation study 16
Potential diagnostic value of CSF metabolism-related proteins across the Alzheimer's disease continuum 15
Investigating alpha-synuclein co-pathology in Alzheimer's disease by means of cerebrospinal fluid alpha-synuclein seed amplification assay 14
Fully automated measurement of plasma Aβ42/40 and p-tau181: Analytical robustness and concordance with cerebrospinal fluid profile along the Alzheimer's disease continuum in two independent cohorts 14
HOPS/TMUB1 Enhances Apoptosis in TP53 Mutation-Independent Setting in Human Cancers 13
CSF and plasma Aβ42/40 across Alzheimer's disease continuum: comparison of two ultrasensitive Simoa® assays targeting distinct amyloid regions 13
Methods to discover and validate biofluid-based biomarkers in neurodegenerative dementias 13
Enhancing mummy ‘palaeobiographies’ though the use of multidisciplinary techniques and approaches 12
Trajectories of CSF and plasma biomarkers across Alzheimer's disease continuum: Disease staging by NF-L, p-tau181, and GFAP 12
Required improvements for cerebrospinal fluid-based biomarker tests of Alzheimer's disease 10
Quantitative SWATH-based proteomic profiling of urine for the identification of endometrial cancer biomarkers in symptomatic women 9
Value of cerebrospinal fluid α-synuclein species as biomarker in Parkinson's diagnosis and prognosis 7
Detection of endometrial cancer in cervico-vaginal fluid and blood plasma: leveraging proteomics and machine learning for biomarker discovery 6
CSF neurosecretory proteins VGF and neuroserpin in patients with Alzheimer's and Lewy body diseases 6
Totale 4.074
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.200
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.200
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020167 0 0 0 0 25 11 23 6 32 50 11 9
2020/2021459 2 20 10 30 171 20 26 18 48 17 30 67
2021/2022717 8 124 15 30 9 9 4 193 45 47 102 131
2022/20231.391 87 272 16 118 96 141 3 67 535 3 38 15
2023/2024613 32 65 45 17 8 4 113 33 70 22 94 110
2024/2025313 30 137 59 77 10 0 0 0 0 0 0 0
Totale 4.084